XNZW:LSE:LSE-Xtrackers World Net Zero Pathway Paris Aligned UCITS ETF 1C (USD)

ETF | Others |

Last Closing

USD 50.0775

Change

-0.15 (-0.30)%

Market Cap

N/A

Volume

1.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-3.05 (-1.64%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.19 (-0.98%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.45%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

-3.55 (-3.26%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.25 (-0.78%)

USD 259.48B
0QZO:LSE 0QZO

-1.10 (-1.21%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-0.40 (-0.27%)

USD 202.26B
0R24:LSE Intel Corp.

N/A

USD 196.14B

ETFs Containing XNZW:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.16% 46% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.16% 45% F 48% F
Trailing 12 Months  
Capital Gain 10.17% 79% B- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.17% 76% C+ 72% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 11.24% 70% C- 72% C
Dividend Return 11.24% 69% C- 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.13% 59% D- 76% C+
Risk Adjusted Return 101.05% 88% B+ 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike